scispace - formally typeset
D

Dafna D. Gladman

Researcher at Toronto Western Hospital

Publications -  1124
Citations -  85280

Dafna D. Gladman is an academic researcher from Toronto Western Hospital. The author has contributed to research in topics: Psoriatic arthritis & Lupus erythematosus. The author has an hindex of 129, co-authored 1036 publications receiving 75273 citations. Previous affiliations of Dafna D. Gladman include Quintiles & University of Utah.

Papers
More filters
Journal ArticleDOI

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

TL;DR: The development of the SLEDAI is described, a validated model of experienced clinicians' global assessments of disease activity in lupus, which represents the consensus of a group of experts in the field of l upus research.
Journal ArticleDOI

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

Michelle Petri, +51 more
TL;DR: The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria in order to improve clinical relevance, meet stringent methodology requirements, and incorporate new knowledge regarding the immunology of SLE.
Journal ArticleDOI

Classification criteria for psoriatic arthritis: Development of new criteria from a large international study

TL;DR: The CASPAR criteria are simple and highly specific but less sensitive than the Vasey and Espinoza criteria and are confirmed as the validity of clinical diagnosis as the gold standard definition of "case"-ness.
Journal Article

Systemic lupus erythematosus disease activity index 2000.

TL;DR: SLEDAI-2K, which allows for persistent activity in rash, mucous membranes, alopecia, and proteinuria, is suitable for use in clinical trials and studies of prognosis in SLE.